From: Glycated hemoglobin and glycated albumin in patients with diabetes undergoing hemodiafiltration
Group A Non-protein-leaking OHDF | Group B Protein-leaking OHDF | Group C Highly efficient protein-leaking OHDF | |
---|---|---|---|
Number of patients | 20 | 14 | 7 |
Insulin users (number) | 3 | 5 | 2 |
Dipeptidyl peptidase-4 inhibitor (number) | 1 | 3 | 2 |
α-Glucosidase inhibitor (number) | 0 | 0 | 1 |
Glucagon-like peptide-1 receptor agonist (number) | 1 | 1 | 0 |
Glinide (number) | 0 | 1 | 2 |
Sulfonylurea (number) | 0 | 0 | 0 |
Non-insulin users (number) | 14 | 7 | 2 |
Dipeptidyl peptidase-4 inhibitor (number) | 13 | 6 | 2 |
α-Glucosidase inhibitor (number) | 5 | 1 | 1 |
Glucagon like peptide-1 receptor agonist (number) | 1 | 1 | 0 |
Glinide (number) | 0 | 3 | 0 |
Sulfonylurea (number) | 1 | 0 | 0 |
Unused diabetes medications (number) | 3 | 2 | 3 |